309 related articles for article (PubMed ID: 38332521)
1. HIV pre-exposure prophylaxis programme preferences among sexually active HIV-negative transgender and gender diverse adults in the United States: a conjoint analysis.
Watson DL; Listerud L; Drab RA; Lin WY; Momplaisir FM; Bauermeister JA
J Int AIDS Soc; 2024 Feb; 27(2):e26211. PubMed ID: 38332521
[TBL] [Abstract][Full Text] [Related]
2. High risk and low uptake of pre-exposure prophylaxis to prevent HIV acquisition in a national online sample of transgender men who have sex with men in the United States.
Reisner SL; Moore CS; Asquith A; Pardee DJ; Sarvet A; Mayer G; Mayer KH
J Int AIDS Soc; 2019 Sep; 22(9):e25391. PubMed ID: 31536171
[TBL] [Abstract][Full Text] [Related]
3. Increasing Access to Pre-Exposure Prophylaxis Among Transgender Women and Transfeminine Nonbinary Individuals.
Klein A; Golub SA
AIDS Patient Care STDS; 2019 Jun; 33(6):262-269. PubMed ID: 31166785
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a pre-exposure prophylaxis programme for men who have sex with men and transgender women in Thailand: learning through the HIV prevention cascade lens.
Ramautarsing RA; Meksena R; Sungsing T; Chinbunchorn T; Sangprasert T; Fungfoosri O; Meekrua D; Sumalu S; Pasansai T; Bunainso W; Wongsri T; Mainoy N; Colby D; Avery M; Mills S; Vannakit R; Phanuphak P; Phanuphak N
J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25540. PubMed ID: 32602660
[TBL] [Abstract][Full Text] [Related]
5. Preferences for pre-exposure prophylaxis among U.S. military men who have sex with men: results of an adaptive choice based conjoint analysis study.
Gutierrez JI; Dubov A; Altice FL; Vlahov D
Mil Med Res; 2021 May; 8(1):32. PubMed ID: 34006328
[TBL] [Abstract][Full Text] [Related]
6. HIV burden and correlates of infection among transfeminine people and cisgender men who have sex with men in Nairobi, Kenya: an observational study.
Smith AD; Kimani J; Kabuti R; Weatherburn P; Fearon E; Bourne A
Lancet HIV; 2021 May; 8(5):e274-e283. PubMed ID: 33631101
[TBL] [Abstract][Full Text] [Related]
7. HIV prevalence and incidence in a cohort of South African men and transgender women who have sex with men: the Sibanye Methods for Prevention Packages Programme (MP3) project.
Sullivan PS; Phaswana-Mafuya N; Baral SD; Valencia R; Zahn R; Dominguez K; Yah CS; Jones J; Kgatitswe LB; McNaghten AD; Siegler AJ; Sanchez TH; Bekker LG
J Int AIDS Soc; 2020 Oct; 23 Suppl 6(Suppl 6):e25591. PubMed ID: 33000918
[TBL] [Abstract][Full Text] [Related]
8. Preferences for long-acting Pre-Exposure Prophylaxis (PrEP) for HIV prevention among South African youth: results of a discrete choice experiment.
Minnis AM; Atujuna M; Browne EN; Ndwayana S; Hartmann M; Sindelo S; Ngcwayi N; Boeri M; Mansfield C; Bekker LG; Montgomery ET
J Int AIDS Soc; 2020 Jun; 23(6):e25528. PubMed ID: 32544303
[TBL] [Abstract][Full Text] [Related]
9. Need for informed providers: exploring LA-PrEP access in focus groups with PrEP-indicated communities in Baltimore, Maryland.
Kaptchuk RP; Thomas AM; Dhir AM; Solomon SS; Clipman SJ
BMC Public Health; 2024 May; 24(1):1258. PubMed ID: 38720248
[TBL] [Abstract][Full Text] [Related]
10. Disparities in the PrEP continuum for trans women compared to MSM in San Francisco, California: results from population-based cross-sectional behavioural surveillance studies.
Wilson EC; Turner CM; Arayasirikul S; Lightfoot M; Scheer S; Raymond HF; Liu A
J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25539. PubMed ID: 32602642
[TBL] [Abstract][Full Text] [Related]
11. Measuring Acceptability and Preferences for Implementation of Pre-Exposure Prophylaxis (PrEP) Using Conjoint Analysis: An Application to Primary HIV Prevention Among High Risk Drug Users.
Shrestha R; Karki P; Altice FL; Dubov O; Fraenkel L; Huedo-Medina T; Copenhaver M
AIDS Behav; 2018 Apr; 22(4):1228-1238. PubMed ID: 28695388
[TBL] [Abstract][Full Text] [Related]
12. HIV Testing and PrEP Use in a National Probability Sample of Sexually Active Transgender People in the United States.
Sevelius JM; Poteat T; Luhur WE; Reisner SL; Meyer IH
J Acquir Immune Defic Syndr; 2020 Aug; 84(5):437-442. PubMed ID: 32692101
[TBL] [Abstract][Full Text] [Related]
13. Willingness and preferences for long-acting injectable PrEP among US men who have sex with men: a discrete choice experiment.
Cole SW; Glick JL; Campoamor NB; Sanchez TH; Sarkar S; Vannappagari V; Rinehart A; Rawlings K; Sullivan PS; Bridges JFP
BMJ Open; 2024 Apr; 14(4):e083837. PubMed ID: 38653510
[TBL] [Abstract][Full Text] [Related]
14. Gender minority stress and access to health care services among transgender women and transfeminine people: results from a cross-sectional study in China.
Sha Y; Dong W; Tang W; Zheng L; Huang X; Muessig KE; Tucker JD
BMC Infect Dis; 2021 Oct; 21(1):1065. PubMed ID: 34649507
[TBL] [Abstract][Full Text] [Related]
15. Optimizing access to PrEP based on MSM preferences: results of a discrete choice experiment.
Dubov A; Ogunbajo A; Altice FL; Fraenkel L
AIDS Care; 2019 May; 31(5):545-553. PubMed ID: 30554519
[TBL] [Abstract][Full Text] [Related]
16. Uptake, Retention, and Adherence to Pre-exposure Prophylaxis (PrEP) in TRIUMPH: A Peer-Led PrEP Demonstration Project for Transgender Communities in Oakland and Sacramento, California.
Sevelius JM; Glidden DV; Deutsch M; Welborn L; Contreras A; Salinas A; Venegas L; Grant RM
J Acquir Immune Defic Syndr; 2021 Dec; 88(S1):S27-S38. PubMed ID: 34757990
[TBL] [Abstract][Full Text] [Related]
17. Population-Level Effectiveness of HIV Pre-exposure Prophylaxis Among MSM and Transgender Persons With Bacterial Sexually Transmitted Infections.
Pagkas-Bather J; Khosropour CM; Golden MR; Thibault C; Dombrowski JC
J Acquir Immune Defic Syndr; 2021 Jun; 87(2):769-775. PubMed ID: 33538527
[TBL] [Abstract][Full Text] [Related]
18. Transgender Women in Clinical Trials of Pre-Exposure Prophylaxis.
Grant RM; Sevelius JM; Guanira JV; Aguilar JV; Chariyalertsak S; Deutsch MB
J Acquir Immune Defic Syndr; 2016 Aug; 72 Suppl 3(Suppl 3):S226-9. PubMed ID: 27429187
[TBL] [Abstract][Full Text] [Related]
19. Implementation of a Test, Treat, and Prevent HIV program among men who have sex with men and transgender women in Thailand, 2015-2016.
Ongwandee S; Lertpiriyasuwat C; Khawcharoenporn T; Chetchotisak P; Thiansukhon E; Leerattanapetch N; Leungwaranan B; Manopaiboon C; Phoorisri T; Visavakum P; Jetsawang B; Poolsawat M; Nookhai S; Vasanti-Uppapokakorn M; Karuchit S; Kittinunvorakoon C; Mock P; Prybylski D; Sukkul AC; Roels T; Martin M
PLoS One; 2018; 13(7):e0201171. PubMed ID: 30044867
[TBL] [Abstract][Full Text] [Related]
20. Cost and cost-effectiveness analysis of pre-exposure prophylaxis among men who have sex with men in two hospitals in Thailand.
Suraratdecha C; Stuart RM; Manopaiboon C; Green D; Lertpiriyasuwat C; Wilson DP; Pavaputanon P; Visavakum P; Monkongdee P; Khawcharoenporn T; Tharee P; Kittinunvorakoon C; Martin M
J Int AIDS Soc; 2018 Jul; 21 Suppl 5(Suppl Suppl 5):e25129. PubMed ID: 30033559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
